Targeting of distinct signaling cascades and cancer-associated fibroblasts define the efficacy of Sorafenib against prostate cancer cells

Pedram Kharaziha(Karolinska University Hospital), Theocharis Panaretakis(The University of Texas MD Anderson Cancer Center)
Cell Death and Disease
January 26, 2012
Cited by 58


Related Papers